Cargando…

Suppression of Occurrence and Advancement of β‐Catenin‐accumulated Crypts, Possible Premalignant Lesions of Colon Cancer, by Selective Cyclooxygenase‐2 Inhibitor, Celecoxib

Suppression of occurrence and advancement of premalignant lesions is important for cancer prevention. Our previous studies clarified that β‐catenin‐accumulated crypts, independent of aberrant crypt foci (ACF), are probably direct precursors of colon cancers in rats. Here we investigated the effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Yasuhiro, Yoshimi, Naoki, Hirose, Yoshinobu, Hara, Akira, Shimizu, Masahito, Kuno, Toshiya, Katayama, Masaki, Qiao, Zheng, Mori, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926764/ https://www.ncbi.nlm.nih.gov/pubmed/11429049 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01139.x

Ejemplares similares

Induction of Apoptosis by Sulindac in Azoxymethane‐induced Possible Colonic Premalignant Lesions in Rats
por: Kuno, Toshiya, et al.
Publicado: (2002)

Inhibitory Effect of NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, on Azoxymethane‐induced Aberrant Crypt Foci in Colon Carcinogenesis of F344 Rats
por: Yoshimi, Naoki, et al.
Publicado: (1997)

Chemopreventive Effect of N‐(2‐Cyclohexyloxy‐4‐nitrophenyl)methane Sulfonamide (NS‐398), a Selective Cyclooxygenase‐2 Inhibitor, in Rat Colon Carcinogenesis Induced by Azoxymethane
por: Yoshimi, Naoki, et al.
Publicado: (1999)

Inhibitory Effects of Nabumetone, a Cyclooxygenase‐2 Inhibitor, and Esculetin, a Lipoxygenase Inhibitor, on N‐Methyl‐N‐nitrosourea‐induced Mammary Carcinogenesis in Rats
por: Matsunaga, Kengo, et al.
Publicado: (1998)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Expression of cyclooxygenase-2 in gastritis and gastric premalignant lesions
por: Rossolymos, Nikolaos A., et al.
Publicado: (2013)

C57BL/KsJ-db/db-Apc(Min/+) Mice Exhibit an Increased Incidence of Intestinal Neoplasms
por: Hata, Kazuya, et al.
Publicado: (2011)

Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
por: Ozawa, Junya, et al.
Publicado: (2016)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy
por: Schönthal, A H
Publicado: (2007)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
por: Pourbakht, Akram
Publicado: (2013)

Suppressing Effects of 6‐(2,5‐Dichlorophenyl)‐2,4‐diamino‐1,3,5‐triazine and Related Synthetic Compounds on Azoxymethane‐induced Aberrant Crypt Foci in Rat Colon
por: Hirose, Yoshinobu, et al.
Publicado: (1996)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
por: Matheny, Ronald W., et al.
Publicado: (2022)

Regressive Effects of Various Chemopreventive Agents on Azoxymethane‐induced Aberrant Crypt Foci in the Rat Colon
por: Morishita, Yukio, et al.
Publicado: (1997)

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
por: Tai, Yang, et al.
Publicado: (2019)

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)

β‐Catenin (Ctnnb1) Gene Mutations in Diethylnitrosamine (DEN)‐induced Liver Tumors in Male F344 Rats
por: Yamada, Yasuhiro, et al.
Publicado: (1999)

Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
Publicado: (2021)

Apoptosis Induced by NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, in Human Colorectal Cancer Cell Lines
por: Kara, Akira, et al.
Publicado: (1997)

Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
por: Kowalczyk, Marek, et al.
Publicado: (2018)

The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci
por: Kowalczyk, Marek, et al.
Publicado: (2022)

Analysis of β-catenin association with obesity in African Americans with premalignant and malignant colorectal lesions
por: Shokrani, Babak, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice
por: Kuno, Toshiya, et al.
Publicado: (2014)

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum
por: NINOMIYA, ITASU, et al.
Publicado: (2012)

Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells
por: Wang, Xinli, et al.
Publicado: (2020)

Oral Premalignancy
por: Hume, W.
Publicado: (1981)

Club in the Crypt
por: Duff, Elizabeth
Publicado: (1967)

Celecoxib and 2,5‐dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β‐catenin signaling pathway
por: Egashira, Issei, et al.
Publicado: (2016)

Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice
por: Fukuta, Kazufumi, et al.
Publicado: (2017)

Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects
por: Liu, T, et al.
Publicado: (2013)

Suppression of Azoxymethane‐induced Rat Colon Aberrant Crypt Foci by Dietary Protocatechuic Acid
por: Kawamori, Toshihiko, et al.
Publicado: (1994)

Soy Saponins Meditate the Progression of Colon Cancer in Rats by Inhibiting the Activity of β-Glucuronidase and the Number of Aberrant Crypt Foci but Not Cyclooxygenase-2 Activity
por: Guo, Yu-Wei, et al.
Publicado: (2013)

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis
por: Sun, Ling
Publicado: (2021)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Tales from the crypt
por: Glaser, Vicki
Publicado: (2001)

Are Hepatic Adenomas Premalignant?
por: Nagorney, David M.
Publicado: (1996)

Premalignant conditions of bone
por: Horvai, Andrew, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_tc36hn3hged577ohqnojsd1260